Fetal outcome following roxithromycin exposure in early pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 3, 2006, Pages 189-192

  Chun, Jun Yang ^a   Han, Jung Yeol ^a,c   Ahn, Hyun Kyong ^a   Choi, June Seek ^a   Koong, Mi Kyoung ^a   Nava Ocampo, Alejandro A ^b   Koren, Gideon ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Sungkyunkwan University   (South Korea)

Author keywords

Congenital malformations; Pregnancy outcome; Prenatal care; Roxithromycin

Indexed keywords

ROXITHROMYCIN;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS; FETUS MALFORMATION; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY;

ADULT; ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; ROXITHROMYCIN;

EID: 33646788386     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500439657     Document Type: Article

References (10)

1. Beri R, Lourwood DL. Chemoprophylaxis for group B streptococcus transmission in neonates. Ann Pharmacother 1997;31:110-112.
2. Duff P. Antibiotic selection in obstetric patients. Infect Dis Clin North Am 1997;11:1-12.
3. Adair CD, Gunter M, Stovall TG, McElroy G, Veille JC, Ernest JM. Chlamydia in pregnancy: A randomized trial of azithromycin and erythromycin. ObstetGynecol 1998;91:165-168.
4. Williams JD, Sefton AM. Comparison of macrolide antibiotics. J Antimicrob Chemother 1993;31 Suppl C:11-26.
5. Markham A, Faulds D. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;48:297-326, 793.
6. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000;107:770-775.
7. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand 2000;79:234-237.
8. Weiner CP, Buhimschi C. Drugs for pregnant and lactating women. New York: Churchill Livingstone; 2004.
9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Baltimore, USA: Williams and Wilkins; 2001.
10. Shepard TH. Catalog of teratogenic agents. 9th ed. Baltimore, USA: John Hopkins University Press; 1998.